nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—Epirubicin—ovarian cancer	0.253	0.354	CbGbCtD
Lomefloxacin—TOP2A—Doxorubicin—ovarian cancer	0.135	0.188	CbGbCtD
Lomefloxacin—ABCC2—Paclitaxel—ovarian cancer	0.102	0.143	CbGbCtD
Lomefloxacin—ABCC2—Carboplatin—ovarian cancer	0.0964	0.135	CbGbCtD
Lomefloxacin—ABCC2—Docetaxel—ovarian cancer	0.0741	0.103	CbGbCtD
Lomefloxacin—ABCC2—Doxorubicin—ovarian cancer	0.0552	0.0771	CbGbCtD
Lomefloxacin—TOP2A—myometrium—ovarian cancer	0.00226	0.101	CbGeAlD
Lomefloxacin—TOP2A—uterine cervix—ovarian cancer	0.00175	0.0789	CbGeAlD
Lomefloxacin—TOP2A—G0 and Early G1—RBL2—ovarian cancer	0.00169	0.0574	CbGpPWpGaD
Lomefloxacin—TOP2A—decidua—ovarian cancer	0.00167	0.0752	CbGeAlD
Lomefloxacin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.00165	0.219	CbGdCrCtD
Lomefloxacin—TOP2A—endometrium—ovarian cancer	0.00159	0.0714	CbGeAlD
Lomefloxacin—TOP2A—uterus—ovarian cancer	0.00146	0.0658	CbGeAlD
Lomefloxacin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.00141	0.187	CbGdCrCtD
Lomefloxacin—ABCC2—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00131	0.0446	CbGpPWpGaD
Lomefloxacin—TOP2A—bone marrow—ovarian cancer	0.00124	0.0558	CbGeAlD
Lomefloxacin—TOP2A—female gonad—ovarian cancer	0.0012	0.0538	CbGeAlD
Lomefloxacin—SLC22A5—myometrium—ovarian cancer	0.00119	0.0537	CbGeAlD
Lomefloxacin—TOP2A—vagina—ovarian cancer	0.00119	0.0535	CbGeAlD
Lomefloxacin—TOP2A—testis—ovarian cancer	0.00106	0.0477	CbGeAlD
Lomefloxacin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.00105	0.139	CbGdCrCtD
Lomefloxacin—SLC22A5—uterine cervix—ovarian cancer	0.000929	0.0418	CbGeAlD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—ovarian cancer	0.000904	0.0307	CbGpPWpGaD
Lomefloxacin—ABCC2—female reproductive system—ovarian cancer	0.000899	0.0404	CbGeAlD
Lomefloxacin—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—ovarian cancer	0.000872	0.0296	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.000848	0.0288	CbGpPWpGaD
Lomefloxacin—SLC22A5—endometrium—ovarian cancer	0.000841	0.0378	CbGeAlD
Lomefloxacin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000824	0.109	CbGdCrCtD
Lomefloxacin—TOP2A—lymph node—ovarian cancer	0.000769	0.0346	CbGeAlD
Lomefloxacin—TOP2A—G0 and Early G1—CCNE1—ovarian cancer	0.000754	0.0256	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—ovarian cancer	0.000744	0.0253	CbGpPWpGaD
Lomefloxacin—ABCC2—testis—ovarian cancer	0.000725	0.0326	CbGeAlD
Lomefloxacin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000719	0.0244	CbGpPWpGaD
Lomefloxacin—SLC22A5—female reproductive system—ovarian cancer	0.000696	0.0313	CbGeAlD
Lomefloxacin—SLC22A5—female gonad—ovarian cancer	0.000634	0.0285	CbGeAlD
Lomefloxacin—SLC22A5—vagina—ovarian cancer	0.00063	0.0283	CbGeAlD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FASN—ovarian cancer	0.000607	0.0206	CbGpPWpGaD
Lomefloxacin—ABCC2—Irinotecan Pathway—APC—ovarian cancer	0.000605	0.0206	CbGpPWpGaD
Lomefloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.000599	0.0203	CbGpPWpGaD
Lomefloxacin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000566	0.075	CbGdCrCtD
Lomefloxacin—SLC22A5—testis—ovarian cancer	0.000562	0.0253	CbGeAlD
Lomefloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.000545	0.0185	CbGpPWpGaD
Lomefloxacin—ABCC2—lymph node—ovarian cancer	0.000526	0.0236	CbGeAlD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000507	0.0172	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—APC—ovarian cancer	0.000483	0.0164	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—ovarian cancer	0.00047	0.016	CbGpPWpGaD
Lomefloxacin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000455	0.0603	CbGdCrCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.000438	0.0149	CbGpPWpGaD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000433	0.0147	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.000414	0.0141	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000413	0.014	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000413	0.014	CbGpPWpGaD
Lomefloxacin—SLC22A5—lymph node—ovarian cancer	0.000407	0.0183	CbGeAlD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.000406	0.0138	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TOP1—ovarian cancer	0.000397	0.0135	CbGpPWpGaD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000394	0.0134	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000347	0.0118	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—RSF1—ovarian cancer	0.000341	0.0116	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.000313	0.0106	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—ovarian cancer	0.000311	0.0106	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—HNF1B—ovarian cancer	0.000301	0.0102	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000291	0.0099	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000278	0.00945	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000277	0.0094	CbGpPWpGaD
Lomefloxacin—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.000276	0.0365	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.000276	0.0365	CbGdCrCtD
Lomefloxacin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.000276	0.0365	CbGdCrCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.000273	0.00928	CbGpPWpGaD
Lomefloxacin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000255	0.0338	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000255	0.0338	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000255	0.0338	CbGdCrCtD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000255	0.00867	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—MYC—ovarian cancer	0.000252	0.00856	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—ovarian cancer	0.000246	0.00837	CbGpPWpGaD
Lomefloxacin—Sparfloxacin—ABCB1—ovarian cancer	0.000241	0.419	CrCbGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000223	0.00759	CbGpPWpGaD
Lomefloxacin—Dry mouth—Paclitaxel—ovarian cancer	0.000219	0.000976	CcSEcCtD
Lomefloxacin—Diarrhoea—Vinorelbine—ovarian cancer	0.000218	0.000973	CcSEcCtD
Lomefloxacin—Dysgeusia—Docetaxel—ovarian cancer	0.000218	0.000973	CcSEcCtD
Lomefloxacin—Ataxia—Doxorubicin—ovarian cancer	0.000217	0.000968	CcSEcCtD
Lomefloxacin—Nausea—Melphalan—ovarian cancer	0.000217	0.000967	CcSEcCtD
Lomefloxacin—Confusional state—Paclitaxel—ovarian cancer	0.000216	0.000965	CcSEcCtD
Lomefloxacin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000216	0.000965	CcSEcCtD
Lomefloxacin—Dysphagia—Epirubicin—ovarian cancer	0.000216	0.000962	CcSEcCtD
Lomefloxacin—Back pain—Docetaxel—ovarian cancer	0.000215	0.000961	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000214	0.000957	CcSEcCtD
Lomefloxacin—Oedema—Paclitaxel—ovarian cancer	0.000214	0.000957	CcSEcCtD
Lomefloxacin—Muscle spasms—Docetaxel—ovarian cancer	0.000214	0.000955	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000214	0.00726	CbGpPWpGaD
Lomefloxacin—Eosinophilia—Epirubicin—ovarian cancer	0.000213	0.000952	CcSEcCtD
Lomefloxacin—Shock—Paclitaxel—ovarian cancer	0.000211	0.000941	CcSEcCtD
Lomefloxacin—Dizziness—Vinorelbine—ovarian cancer	0.000211	0.00094	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000211	0.00716	CbGpPWpGaD
Lomefloxacin—Angina pectoris—Epirubicin—ovarian cancer	0.00021	0.000937	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00021	0.000937	CcSEcCtD
Lomefloxacin—Tachycardia—Paclitaxel—ovarian cancer	0.000209	0.000934	CcSEcCtD
Lomefloxacin—Skin disorder—Paclitaxel—ovarian cancer	0.000208	0.000929	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000208	0.000927	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000207	0.000925	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—ovarian cancer	0.000207	0.00703	CbGpPWpGaD
Lomefloxacin—Anaemia—Docetaxel—ovarian cancer	0.000206	0.000918	CcSEcCtD
Lomefloxacin—Anorexia—Paclitaxel—ovarian cancer	0.000204	0.000912	CcSEcCtD
Lomefloxacin—Vomiting—Vinorelbine—ovarian cancer	0.000203	0.000904	CcSEcCtD
Lomefloxacin—Dysuria—Epirubicin—ovarian cancer	0.000202	0.000899	CcSEcCtD
Lomefloxacin—Rash—Vinorelbine—ovarian cancer	0.000201	0.000897	CcSEcCtD
Lomefloxacin—Dermatitis—Vinorelbine—ovarian cancer	0.000201	0.000896	CcSEcCtD
Lomefloxacin—Hypotension—Paclitaxel—ovarian cancer	0.0002	0.000894	CcSEcCtD
Lomefloxacin—Headache—Vinorelbine—ovarian cancer	0.0002	0.000891	CcSEcCtD
Lomefloxacin—Syncope—Docetaxel—ovarian cancer	0.0002	0.000891	CcSEcCtD
Lomefloxacin—Dysphagia—Doxorubicin—ovarian cancer	0.000199	0.00089	CcSEcCtD
Lomefloxacin—Leukopenia—Docetaxel—ovarian cancer	0.000199	0.000889	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000198	0.00671	CbGpPWpGaD
Lomefloxacin—Eosinophilia—Doxorubicin—ovarian cancer	0.000197	0.000881	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000197	0.000878	CcSEcCtD
Lomefloxacin—Loss of consciousness—Docetaxel—ovarian cancer	0.000196	0.000873	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000196	0.00665	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000195	0.000872	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Epirubicin—ovarian cancer	0.000194	0.000868	CcSEcCtD
Lomefloxacin—Cough—Docetaxel—ovarian cancer	0.000194	0.000867	CcSEcCtD
Lomefloxacin—Angina pectoris—Doxorubicin—ovarian cancer	0.000194	0.000867	CcSEcCtD
Lomefloxacin—Insomnia—Paclitaxel—ovarian cancer	0.000194	0.000865	CcSEcCtD
Lomefloxacin—Convulsion—Docetaxel—ovarian cancer	0.000193	0.000861	CcSEcCtD
Lomefloxacin—Paraesthesia—Paclitaxel—ovarian cancer	0.000193	0.000859	CcSEcCtD
Lomefloxacin—Hypertension—Docetaxel—ovarian cancer	0.000192	0.000858	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—ovarian cancer	0.000192	0.00653	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Paclitaxel—ovarian cancer	0.000191	0.000853	CcSEcCtD
Lomefloxacin—Somnolence—Paclitaxel—ovarian cancer	0.000191	0.00085	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000191	0.00085	CcSEcCtD
Lomefloxacin—Myalgia—Docetaxel—ovarian cancer	0.00019	0.000846	CcSEcCtD
Lomefloxacin—Chest pain—Docetaxel—ovarian cancer	0.00019	0.000846	CcSEcCtD
Lomefloxacin—Arthralgia—Docetaxel—ovarian cancer	0.00019	0.000846	CcSEcCtD
Lomefloxacin—Nausea—Vinorelbine—ovarian cancer	0.000189	0.000845	CcSEcCtD
Lomefloxacin—Renal failure—Epirubicin—ovarian cancer	0.000189	0.000843	CcSEcCtD
Lomefloxacin—Dyspepsia—Paclitaxel—ovarian cancer	0.000189	0.000842	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000188	0.000841	CcSEcCtD
Lomefloxacin—Stomatitis—Epirubicin—ovarian cancer	0.000187	0.000836	CcSEcCtD
Lomefloxacin—Conjunctivitis—Epirubicin—ovarian cancer	0.000187	0.000834	CcSEcCtD
Lomefloxacin—Dysuria—Doxorubicin—ovarian cancer	0.000186	0.000832	CcSEcCtD
Lomefloxacin—Decreased appetite—Paclitaxel—ovarian cancer	0.000186	0.000832	CcSEcCtD
Lomefloxacin—Dry mouth—Docetaxel—ovarian cancer	0.000185	0.000827	CcSEcCtD
Lomefloxacin—Fatigue—Paclitaxel—ovarian cancer	0.000185	0.000825	CcSEcCtD
Lomefloxacin—Constipation—Paclitaxel—ovarian cancer	0.000183	0.000818	CcSEcCtD
Lomefloxacin—Haematuria—Epirubicin—ovarian cancer	0.000183	0.000818	CcSEcCtD
Lomefloxacin—Confusional state—Docetaxel—ovarian cancer	0.000183	0.000818	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000182	0.000812	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000182	0.000811	CcSEcCtD
Lomefloxacin—Oedema—Docetaxel—ovarian cancer	0.000182	0.000811	CcSEcCtD
Lomefloxacin—Epistaxis—Epirubicin—ovarian cancer	0.000181	0.000809	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000181	0.00614	CbGpPWpGaD
Lomefloxacin—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00018	0.000803	CcSEcCtD
Lomefloxacin—Agranulocytosis—Epirubicin—ovarian cancer	0.000179	0.0008	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—RAD51C—ovarian cancer	0.000179	0.00608	CbGpPWpGaD
Lomefloxacin—Shock—Docetaxel—ovarian cancer	0.000179	0.000798	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000178	0.000794	CcSEcCtD
Lomefloxacin—Tachycardia—Docetaxel—ovarian cancer	0.000177	0.000791	CcSEcCtD
Lomefloxacin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000177	0.000788	CcSEcCtD
Lomefloxacin—Skin disorder—Docetaxel—ovarian cancer	0.000176	0.000788	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000176	0.000787	CcSEcCtD
Lomefloxacin—Bradycardia—Epirubicin—ovarian cancer	0.000176	0.000784	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000175	0.000782	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000175	0.00594	CbGpPWpGaD
Lomefloxacin—Renal failure—Doxorubicin—ovarian cancer	0.000175	0.00078	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000174	0.000778	CcSEcCtD
Lomefloxacin—Stomatitis—Doxorubicin—ovarian cancer	0.000173	0.000773	CcSEcCtD
Lomefloxacin—Anorexia—Docetaxel—ovarian cancer	0.000173	0.000773	CcSEcCtD
Lomefloxacin—Rhinitis—Epirubicin—ovarian cancer	0.000173	0.000772	CcSEcCtD
Lomefloxacin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000173	0.000771	CcSEcCtD
Lomefloxacin—Hepatitis—Epirubicin—ovarian cancer	0.000173	0.00077	CcSEcCtD
Lomefloxacin—Pharyngitis—Epirubicin—ovarian cancer	0.000171	0.000764	CcSEcCtD
Lomefloxacin—Urticaria—Paclitaxel—ovarian cancer	0.00017	0.00076	CcSEcCtD
Lomefloxacin—Hypotension—Docetaxel—ovarian cancer	0.00017	0.000758	CcSEcCtD
Lomefloxacin—Haematuria—Doxorubicin—ovarian cancer	0.00017	0.000757	CcSEcCtD
Lomefloxacin—Abdominal pain—Paclitaxel—ovarian cancer	0.000169	0.000756	CcSEcCtD
Lomefloxacin—Levofloxacin—ABCB1—ovarian cancer	0.000169	0.295	CrCbGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000169	0.00575	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC5A5—ovarian cancer	0.000169	0.00573	CbGpPWpGaD
Lomefloxacin—Epistaxis—Doxorubicin—ovarian cancer	0.000168	0.000748	CcSEcCtD
Lomefloxacin—Visual impairment—Epirubicin—ovarian cancer	0.000166	0.000742	CcSEcCtD
Lomefloxacin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000166	0.00074	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000166	0.000739	CcSEcCtD
Lomefloxacin—Insomnia—Docetaxel—ovarian cancer	0.000164	0.000733	CcSEcCtD
Lomefloxacin—Ciprofloxacin—ABCB1—ovarian cancer	0.000164	0.285	CrCbGaD
Lomefloxacin—Paraesthesia—Docetaxel—ovarian cancer	0.000163	0.000728	CcSEcCtD
Lomefloxacin—Erythema multiforme—Epirubicin—ovarian cancer	0.000163	0.000728	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SLC2A1—ovarian cancer	0.000163	0.00554	CbGpPWpGaD
Lomefloxacin—Bradycardia—Doxorubicin—ovarian cancer	0.000162	0.000725	CcSEcCtD
Lomefloxacin—Dyspnoea—Docetaxel—ovarian cancer	0.000162	0.000723	CcSEcCtD
Lomefloxacin—Somnolence—Docetaxel—ovarian cancer	0.000162	0.000721	CcSEcCtD
Lomefloxacin—Tinnitus—Epirubicin—ovarian cancer	0.000161	0.000718	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.000161	0.00546	CbGpPWpGaD
Lomefloxacin—Flushing—Epirubicin—ovarian cancer	0.00016	0.000714	CcSEcCtD
Lomefloxacin—Rhinitis—Doxorubicin—ovarian cancer	0.00016	0.000714	CcSEcCtD
Lomefloxacin—Dyspepsia—Docetaxel—ovarian cancer	0.00016	0.000714	CcSEcCtD
Lomefloxacin—Hepatitis—Doxorubicin—ovarian cancer	0.00016	0.000712	CcSEcCtD
Lomefloxacin—Pharyngitis—Doxorubicin—ovarian cancer	0.000158	0.000707	CcSEcCtD
Lomefloxacin—Decreased appetite—Docetaxel—ovarian cancer	0.000158	0.000705	CcSEcCtD
Lomefloxacin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000158	0.000705	CcSEcCtD
Lomefloxacin—Fatigue—Docetaxel—ovarian cancer	0.000157	0.000699	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—PPP1CC—ovarian cancer	0.000156	0.00532	CbGpPWpGaD
Lomefloxacin—Constipation—Docetaxel—ovarian cancer	0.000155	0.000693	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000155	0.00527	CbGpPWpGaD
Lomefloxacin—Chills—Epirubicin—ovarian cancer	0.000155	0.000691	CcSEcCtD
Lomefloxacin—Arrhythmia—Epirubicin—ovarian cancer	0.000154	0.000688	CcSEcCtD
Lomefloxacin—Visual impairment—Doxorubicin—ovarian cancer	0.000154	0.000686	CcSEcCtD
Lomefloxacin—Asthenia—Paclitaxel—ovarian cancer	0.000154	0.000686	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000153	0.0052	CbGpPWpGaD
Lomefloxacin—Pruritus—Paclitaxel—ovarian cancer	0.000152	0.000677	CcSEcCtD
Lomefloxacin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000151	0.000673	CcSEcCtD
Lomefloxacin—Feeling abnormal—Docetaxel—ovarian cancer	0.00015	0.000668	CcSEcCtD
Lomefloxacin—Tinnitus—Doxorubicin—ovarian cancer	0.000149	0.000664	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000149	0.000663	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000148	0.00504	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000148	0.00504	CbGpPWpGaD
Lomefloxacin—Flushing—Doxorubicin—ovarian cancer	0.000148	0.000661	CcSEcCtD
Lomefloxacin—Flatulence—Epirubicin—ovarian cancer	0.000148	0.00066	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.000148	0.00502	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000148	0.00502	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.000148	0.00502	CbGpPWpGaD
Lomefloxacin—Tension—Epirubicin—ovarian cancer	0.000147	0.000658	CcSEcCtD
Lomefloxacin—Dysgeusia—Epirubicin—ovarian cancer	0.000147	0.000656	CcSEcCtD
Lomefloxacin—Diarrhoea—Paclitaxel—ovarian cancer	0.000147	0.000655	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000146	0.00497	CbGpPWpGaD
Lomefloxacin—Nervousness—Epirubicin—ovarian cancer	0.000146	0.000651	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000146	0.00495	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000145	0.00494	CbGpPWpGaD
Lomefloxacin—Back pain—Epirubicin—ovarian cancer	0.000145	0.000648	CcSEcCtD
Lomefloxacin—Muscle spasms—Epirubicin—ovarian cancer	0.000144	0.000644	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000144	0.0049	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Docetaxel—ovarian cancer	0.000144	0.000641	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—RBL2—ovarian cancer	0.000144	0.00488	CbGpPWpGaD
Lomefloxacin—Chills—Doxorubicin—ovarian cancer	0.000143	0.000639	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.000143	0.00485	CbGpPWpGaD
Lomefloxacin—Arrhythmia—Doxorubicin—ovarian cancer	0.000143	0.000636	CcSEcCtD
Lomefloxacin—Dizziness—Paclitaxel—ovarian cancer	0.000142	0.000633	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.00014	0.00477	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00014	0.00476	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	0.00014	0.00475	CbGpPWpGaD
Lomefloxacin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000139	0.000622	CcSEcCtD
Lomefloxacin—Anaemia—Epirubicin—ovarian cancer	0.000139	0.000619	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000138	0.0047	CbGpPWpGaD
Lomefloxacin—Agitation—Epirubicin—ovarian cancer	0.000138	0.000616	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000137	0.00467	CbGpPWpGaD
Lomefloxacin—Flatulence—Doxorubicin—ovarian cancer	0.000137	0.000611	CcSEcCtD
Lomefloxacin—Tension—Doxorubicin—ovarian cancer	0.000136	0.000608	CcSEcCtD
Lomefloxacin—Vomiting—Paclitaxel—ovarian cancer	0.000136	0.000608	CcSEcCtD
Lomefloxacin—Dysgeusia—Doxorubicin—ovarian cancer	0.000136	0.000607	CcSEcCtD
Lomefloxacin—Malaise—Epirubicin—ovarian cancer	0.000135	0.000604	CcSEcCtD
Lomefloxacin—Rash—Paclitaxel—ovarian cancer	0.000135	0.000603	CcSEcCtD
Lomefloxacin—Dermatitis—Paclitaxel—ovarian cancer	0.000135	0.000603	CcSEcCtD
Lomefloxacin—Nervousness—Doxorubicin—ovarian cancer	0.000135	0.000602	CcSEcCtD
Lomefloxacin—Vertigo—Epirubicin—ovarian cancer	0.000135	0.000602	CcSEcCtD
Lomefloxacin—Syncope—Epirubicin—ovarian cancer	0.000135	0.000601	CcSEcCtD
Lomefloxacin—Leukopenia—Epirubicin—ovarian cancer	0.000134	0.0006	CcSEcCtD
Lomefloxacin—Back pain—Doxorubicin—ovarian cancer	0.000134	0.0006	CcSEcCtD
Lomefloxacin—Headache—Paclitaxel—ovarian cancer	0.000134	0.000599	CcSEcCtD
Lomefloxacin—Hypersensitivity—Docetaxel—ovarian cancer	0.000134	0.000597	CcSEcCtD
Lomefloxacin—Muscle spasms—Doxorubicin—ovarian cancer	0.000134	0.000596	CcSEcCtD
Lomefloxacin—Loss of consciousness—Epirubicin—ovarian cancer	0.000132	0.000589	CcSEcCtD
Lomefloxacin—Cough—Epirubicin—ovarian cancer	0.000131	0.000585	CcSEcCtD
Lomefloxacin—Asthenia—Docetaxel—ovarian cancer	0.00013	0.000582	CcSEcCtD
Lomefloxacin—Convulsion—Epirubicin—ovarian cancer	0.00013	0.000581	CcSEcCtD
Lomefloxacin—Hypertension—Epirubicin—ovarian cancer	0.00013	0.000579	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000129	0.000575	CcSEcCtD
Lomefloxacin—Pruritus—Docetaxel—ovarian cancer	0.000129	0.000574	CcSEcCtD
Lomefloxacin—Anaemia—Doxorubicin—ovarian cancer	0.000128	0.000573	CcSEcCtD
Lomefloxacin—Arthralgia—Epirubicin—ovarian cancer	0.000128	0.000571	CcSEcCtD
Lomefloxacin—Chest pain—Epirubicin—ovarian cancer	0.000128	0.000571	CcSEcCtD
Lomefloxacin—Myalgia—Epirubicin—ovarian cancer	0.000128	0.000571	CcSEcCtD
Lomefloxacin—Agitation—Doxorubicin—ovarian cancer	0.000128	0.00057	CcSEcCtD
Lomefloxacin—Anxiety—Epirubicin—ovarian cancer	0.000127	0.000569	CcSEcCtD
Lomefloxacin—Nausea—Paclitaxel—ovarian cancer	0.000127	0.000568	CcSEcCtD
Lomefloxacin—Discomfort—Epirubicin—ovarian cancer	0.000126	0.000564	CcSEcCtD
Lomefloxacin—Malaise—Doxorubicin—ovarian cancer	0.000125	0.000559	CcSEcCtD
Lomefloxacin—Dry mouth—Epirubicin—ovarian cancer	0.000125	0.000558	CcSEcCtD
Lomefloxacin—Vertigo—Doxorubicin—ovarian cancer	0.000125	0.000557	CcSEcCtD
Lomefloxacin—Syncope—Doxorubicin—ovarian cancer	0.000125	0.000556	CcSEcCtD
Lomefloxacin—Leukopenia—Doxorubicin—ovarian cancer	0.000124	0.000555	CcSEcCtD
Lomefloxacin—Diarrhoea—Docetaxel—ovarian cancer	0.000124	0.000555	CcSEcCtD
Lomefloxacin—Confusional state—Epirubicin—ovarian cancer	0.000124	0.000551	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000123	0.000547	CcSEcCtD
Lomefloxacin—Oedema—Epirubicin—ovarian cancer	0.000123	0.000547	CcSEcCtD
Lomefloxacin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000122	0.000545	CcSEcCtD
Lomefloxacin—Cough—Doxorubicin—ovarian cancer	0.000121	0.000541	CcSEcCtD
Lomefloxacin—Shock—Epirubicin—ovarian cancer	0.000121	0.000538	CcSEcCtD
Lomefloxacin—Convulsion—Doxorubicin—ovarian cancer	0.00012	0.000537	CcSEcCtD
Lomefloxacin—Dizziness—Docetaxel—ovarian cancer	0.00012	0.000536	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Epirubicin—ovarian cancer	0.00012	0.000535	CcSEcCtD
Lomefloxacin—Hypertension—Doxorubicin—ovarian cancer	0.00012	0.000535	CcSEcCtD
Lomefloxacin—Tachycardia—Epirubicin—ovarian cancer	0.00012	0.000534	CcSEcCtD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000119	0.00406	CbGpPWpGaD
Lomefloxacin—Skin disorder—Epirubicin—ovarian cancer	0.000119	0.000531	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000118	0.000529	CcSEcCtD
Lomefloxacin—Myalgia—Doxorubicin—ovarian cancer	0.000118	0.000528	CcSEcCtD
Lomefloxacin—Chest pain—Doxorubicin—ovarian cancer	0.000118	0.000528	CcSEcCtD
Lomefloxacin—Arthralgia—Doxorubicin—ovarian cancer	0.000118	0.000528	CcSEcCtD
Lomefloxacin—Anxiety—Doxorubicin—ovarian cancer	0.000118	0.000526	CcSEcCtD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000118	0.00401	CbGpPWpGaD
Lomefloxacin—Discomfort—Doxorubicin—ovarian cancer	0.000117	0.000522	CcSEcCtD
Lomefloxacin—Anorexia—Epirubicin—ovarian cancer	0.000117	0.000521	CcSEcCtD
Lomefloxacin—Dry mouth—Doxorubicin—ovarian cancer	0.000116	0.000516	CcSEcCtD
Lomefloxacin—Vomiting—Docetaxel—ovarian cancer	0.000116	0.000516	CcSEcCtD
Lomefloxacin—Rash—Docetaxel—ovarian cancer	0.000115	0.000511	CcSEcCtD
Lomefloxacin—Hypotension—Epirubicin—ovarian cancer	0.000115	0.000511	CcSEcCtD
Lomefloxacin—Dermatitis—Docetaxel—ovarian cancer	0.000114	0.000511	CcSEcCtD
Lomefloxacin—Confusional state—Doxorubicin—ovarian cancer	0.000114	0.00051	CcSEcCtD
Lomefloxacin—Headache—Docetaxel—ovarian cancer	0.000114	0.000508	CcSEcCtD
Lomefloxacin—Oedema—Doxorubicin—ovarian cancer	0.000113	0.000506	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000113	0.000506	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000113	0.00384	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000112	0.000498	CcSEcCtD
Lomefloxacin—Shock—Doxorubicin—ovarian cancer	0.000112	0.000498	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000111	0.000495	CcSEcCtD
Lomefloxacin—Insomnia—Epirubicin—ovarian cancer	0.000111	0.000495	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000111	0.00376	CbGpPWpGaD
Lomefloxacin—Tachycardia—Doxorubicin—ovarian cancer	0.000111	0.000494	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.00011	0.00375	CbGpPWpGaD
Lomefloxacin—Skin disorder—Doxorubicin—ovarian cancer	0.00011	0.000492	CcSEcCtD
Lomefloxacin—Paraesthesia—Epirubicin—ovarian cancer	0.00011	0.000491	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00011	0.000489	CcSEcCtD
Lomefloxacin—Dyspnoea—Epirubicin—ovarian cancer	0.000109	0.000488	CcSEcCtD
Lomefloxacin—Somnolence—Epirubicin—ovarian cancer	0.000109	0.000486	CcSEcCtD
Lomefloxacin—Anorexia—Doxorubicin—ovarian cancer	0.000108	0.000482	CcSEcCtD
Lomefloxacin—Nausea—Docetaxel—ovarian cancer	0.000108	0.000482	CcSEcCtD
Lomefloxacin—Dyspepsia—Epirubicin—ovarian cancer	0.000108	0.000481	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000107	0.00363	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000107	0.00363	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000107	0.00363	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Epirubicin—ovarian cancer	0.000107	0.000475	CcSEcCtD
Lomefloxacin—Hypotension—Doxorubicin—ovarian cancer	0.000106	0.000473	CcSEcCtD
Lomefloxacin—Fatigue—Epirubicin—ovarian cancer	0.000106	0.000472	CcSEcCtD
Lomefloxacin—Constipation—Epirubicin—ovarian cancer	0.000105	0.000468	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000103	0.000461	CcSEcCtD
Lomefloxacin—Insomnia—Doxorubicin—ovarian cancer	0.000103	0.000458	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000102	0.00348	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Doxorubicin—ovarian cancer	0.000102	0.000454	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000101	0.00345	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Doxorubicin—ovarian cancer	0.000101	0.000451	CcSEcCtD
Lomefloxacin—Feeling abnormal—Epirubicin—ovarian cancer	0.000101	0.000451	CcSEcCtD
Lomefloxacin—Somnolence—Doxorubicin—ovarian cancer	0.000101	0.00045	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.0001	0.000447	CcSEcCtD
Lomefloxacin—Dyspepsia—Doxorubicin—ovarian cancer	9.98e-05	0.000445	CcSEcCtD
Lomefloxacin—Decreased appetite—Doxorubicin—ovarian cancer	9.86e-05	0.00044	CcSEcCtD
Lomefloxacin—Fatigue—Doxorubicin—ovarian cancer	9.78e-05	0.000436	CcSEcCtD
Lomefloxacin—Urticaria—Epirubicin—ovarian cancer	9.74e-05	0.000434	CcSEcCtD
Lomefloxacin—Constipation—Doxorubicin—ovarian cancer	9.7e-05	0.000433	CcSEcCtD
Lomefloxacin—Abdominal pain—Epirubicin—ovarian cancer	9.69e-05	0.000432	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	9.68e-05	0.00329	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	9.67e-05	0.00329	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MLH1—ovarian cancer	9.66e-05	0.00328	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—SKP2—ovarian cancer	9.56e-05	0.00325	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Doxorubicin—ovarian cancer	9.35e-05	0.000417	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	9.28e-05	0.00315	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.27e-05	0.000414	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	9.06e-05	0.00308	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Epirubicin—ovarian cancer	9.03e-05	0.000403	CcSEcCtD
Lomefloxacin—Urticaria—Doxorubicin—ovarian cancer	9.01e-05	0.000402	CcSEcCtD
Lomefloxacin—Abdominal pain—Doxorubicin—ovarian cancer	8.96e-05	0.0004	CcSEcCtD
Lomefloxacin—Asthenia—Epirubicin—ovarian cancer	8.79e-05	0.000392	CcSEcCtD
Lomefloxacin—Pruritus—Epirubicin—ovarian cancer	8.67e-05	0.000387	CcSEcCtD
Lomefloxacin—Diarrhoea—Epirubicin—ovarian cancer	8.39e-05	0.000374	CcSEcCtD
Lomefloxacin—Hypersensitivity—Doxorubicin—ovarian cancer	8.36e-05	0.000373	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	8.29e-05	0.00282	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	8.19e-05	0.00278	CbGpPWpGaD
Lomefloxacin—Asthenia—Doxorubicin—ovarian cancer	8.14e-05	0.000363	CcSEcCtD
Lomefloxacin—Dizziness—Epirubicin—ovarian cancer	8.1e-05	0.000362	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.1e-05	0.00275	CbGpPWpGaD
Lomefloxacin—Pruritus—Doxorubicin—ovarian cancer	8.02e-05	0.000358	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CHEK2—ovarian cancer	7.82e-05	0.00266	CbGpPWpGaD
Lomefloxacin—Vomiting—Epirubicin—ovarian cancer	7.79e-05	0.000348	CcSEcCtD
Lomefloxacin—Diarrhoea—Doxorubicin—ovarian cancer	7.76e-05	0.000346	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	7.76e-05	0.00264	CbGpPWpGaD
Lomefloxacin—Rash—Epirubicin—ovarian cancer	7.73e-05	0.000345	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	7.73e-05	0.00263	CbGpPWpGaD
Lomefloxacin—Dermatitis—Epirubicin—ovarian cancer	7.72e-05	0.000345	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	7.68e-05	0.00261	CbGpPWpGaD
Lomefloxacin—Headache—Epirubicin—ovarian cancer	7.68e-05	0.000343	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	7.53e-05	0.00256	CbGpPWpGaD
Lomefloxacin—Dizziness—Doxorubicin—ovarian cancer	7.5e-05	0.000335	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.39e-05	0.00251	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	7.33e-05	0.00249	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND2—ovarian cancer	7.32e-05	0.00249	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BRCA1—ovarian cancer	7.32e-05	0.00249	CbGpPWpGaD
Lomefloxacin—Nausea—Epirubicin—ovarian cancer	7.28e-05	0.000325	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	7.26e-05	0.00247	CbGpPWpGaD
Lomefloxacin—Vomiting—Doxorubicin—ovarian cancer	7.21e-05	0.000322	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	7.17e-05	0.00244	CbGpPWpGaD
Lomefloxacin—Rash—Doxorubicin—ovarian cancer	7.15e-05	0.000319	CcSEcCtD
Lomefloxacin—Dermatitis—Doxorubicin—ovarian cancer	7.14e-05	0.000319	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.14e-05	0.00243	CbGpPWpGaD
Lomefloxacin—Headache—Doxorubicin—ovarian cancer	7.1e-05	0.000317	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	7.07e-05	0.0024	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	7.05e-05	0.00239	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	6.91e-05	0.00235	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	6.79e-05	0.00231	CbGpPWpGaD
Lomefloxacin—Nausea—Doxorubicin—ovarian cancer	6.74e-05	0.000301	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—BRCA2—ovarian cancer	6.62e-05	0.00225	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCNE1—ovarian cancer	6.41e-05	0.00218	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	6.39e-05	0.00217	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	6.34e-05	0.00215	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	6.31e-05	0.00214	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	6.31e-05	0.00214	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TYMS—ovarian cancer	6.3e-05	0.00214	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	6.17e-05	0.0021	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	6.04e-05	0.00205	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.88e-05	0.002	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.75e-05	0.00195	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.75e-05	0.00195	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—ovarian cancer	5.67e-05	0.00193	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.64e-05	0.00192	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TERT—ovarian cancer	5.49e-05	0.00187	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.43e-05	0.00185	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.4e-05	0.00184	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	5.24e-05	0.00178	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.22e-05	0.00177	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	5.18e-05	0.00176	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	5.14e-05	0.00175	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	5.07e-05	0.00172	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.99e-05	0.0017	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.83e-05	0.00164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	4.83e-05	0.00164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	4.72e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	4.72e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	4.72e-05	0.0016	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	4.63e-05	0.00157	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	4.46e-05	0.00152	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	4.24e-05	0.00144	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.12e-05	0.0014	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.08e-05	0.00139	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.97e-05	0.00135	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	3.79e-05	0.00129	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.72e-05	0.00126	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.55e-05	0.00121	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	3.32e-05	0.00113	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—ovarian cancer	3.17e-05	0.00108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NME2—ovarian cancer	3.14e-05	0.00107	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.93e-05	0.000994	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	2.85e-05	0.000967	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.78e-05	0.000946	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.66e-05	0.000904	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	2.62e-05	0.000889	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—ovarian cancer	2.54e-05	0.000865	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	2.49e-05	0.000846	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.17e-05	0.000737	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—ovarian cancer	2.09e-05	0.00071	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYTB—ovarian cancer	2.02e-05	0.000687	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.98e-05	0.000671	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.77e-05	0.0006	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.77e-05	0.0006	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.29e-05	0.000437	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—YAP1—ovarian cancer	1.18e-05	0.000403	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.17e-05	0.000398	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.03e-05	0.00035	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FASN—ovarian cancer	9.66e-06	0.000328	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	9.5e-06	0.000323	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	9.18e-06	0.000312	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.98e-06	0.000305	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	8.8e-06	0.000299	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	7.8e-06	0.000265	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.76e-06	0.000264	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCB1—ovarian cancer	7.24e-06	0.000246	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TYMS—ovarian cancer	7.11e-06	0.000242	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAV1—ovarian cancer	5.73e-06	0.000195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.48e-06	0.000186	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	5.22e-06	0.000177	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.59e-06	0.000156	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	4e-06	0.000136	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTEN—ovarian cancer	3.46e-06	0.000118	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.44e-06	8.29e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—ovarian cancer	1.99e-06	6.77e-05	CbGpPWpGaD
